— Know what they know.
Not Investment Advice

ZOM AMEX

Zomedica Corp.
1W: -4.4% 1M: -39.2% 3M: -51.1% 1Y: -59.4% 3Y: -82.3% 5Y: -64.7%
$0.10
Last traded 2025-04-01 — delisted
AMEX · Healthcare · Drug Manufacturers - Specialty & Generic · $95.3M mcap · 962M float · 0.888% daily turnover

Balance Sheet Trends

Total Assets
$127M -38.7% ▼
5Y CAGR: +13.9%
Total Liabilities
$12M -0.5% ▼
5Y CAGR: -5.0%
Shareholders Equity
$115M -41.0% ▼
5Y CAGR: +17.7%
Cash & Investments
$53M -25.4% ▼
5Y CAGR: -3.0%
Total Debt
$717K -60.5% ▼
5Y CAGR: -17.4%
Net Debt
-$8M -59.4% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025FY2026
— Assets —
Cash$195M$27M$13M$7M$9M
Short-Term Investments$0$88M$78M$64M$44M
Cash & ST Investments$195M$115M$90M$71M$53M
Net Receivables$765K$2M$2M$3M$3M
Inventory$3M$3M$5M$5M$6M
Other Current Assets$1M$2M$0$0$2M
Total Current Assets$200M$124M$100M$82M$64M
Property, Plant & Equip.$3M$9M$25M$26M$23M
Goodwill & Intangibles$77M$106M$117M$98M$39M
Long-Term Investments$0$41M$10M$0$0
Other Non-Current Assets$659K$453K$1M$1M$1M
Total Non-Current Assets$80M$156M$153M$126M$63M
Total Assets$280M$280M$253M$207M$127M
— Liabilities —
Accounts Payable$3M$7M$8M$2M$2M
Short-Term Debt$415K$641K$0$523K$717K
Deferred Revenue$198K$207K$276K$331K$0
Other Current Liabilities$285K-$376K$107K$5M$7M
Total Current Liabilities$4M$8M$9M$9M$9M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$361K$2M$944K$399K$2M
Total Non-Current Liabilities$5M$4M$4M$2M$2M
Total Liabilities$10M$12M$13M$12M$12M
— Equity —
Common Stock$381M$381M$381M$381M$381M
Retained Earnings-$119M-$136M-$171M-$218M-$300M
Accumulated OCI$2K-$843K$48K$88K$160K
Total Stockholders Equity$271M$267M$240M$196M$115M
Total Liabilities & Equity$280M$280M$253M$207M$127M
— Key Metrics —
Total Debt$1M$2M$3M$2M$717K
Net Debt-$194M-$26M-$10M-$5M-$8M
Total Investments$0$128M$88M$64M$44M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms